Product Name | DBeQ |
Description |
p97 inhibitor |
Purity | >98% |
Molecular Formula | C22H20N4 |
Molecular Weight | 340.4 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | Soluble in 25 mg/ml DMSO |
Source | Synthetic |
Appearance | Yellow Powder |
SMILES | C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)NCC4=CC=CC=C4 |
InChI | InChI=1S/C22H20N4/c1-3-9-17(10-4-1)15-23-21-19-13-7-8-14-20(19)25-22(26-21)24-16-18-11-5-2-6-12-18/h1-14H,15-16H2,(H2,23,24,25,26) |
InChIKey | QAIMUUJJAJBPCL-UHFFFAOYSA-N |
Safety Phrases |
Classification: Toxic Material Causing other toxic effects- moderate eye irritant. Safety Phrases: S22 - Do not breathe dust S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection S24/25- Avoid contact with skin and eyes Hazard Statements: H302 – Harmful if swallowed Precautionary Statements: P305 + P351 + P338 – If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
Cite This Product | DBeQ (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-334) |
Alternative Names | N,N'-Dibenzyl-2,4-quinazolinediamine, JRF 12, N2,N4-dibenzylquinazoline-2,4-diamine, N2,N4-Bis(phenylmethyl)-2,4-quinazolinediamine |
Research Areas | Apoptosis, Cancer |
PubChem ID | 676352 |
Scientific Background | A potent, selective and reversible inhibitor of the AAA-ATP p97 (ATPase associated with diverse cellular activities). Ki=3.2 M. It blocks ubiquitin-dependent protein clearance pathways. Cell permeable. |
References | 1. Chou T.F., et al. 2011 PNAS 108:4834. |
Reviews
There are no reviews yet.